R
Rafael Franco
Researcher at University of Barcelona
Publications - 466
Citations - 25227
Rafael Franco is an academic researcher from University of Barcelona. The author has contributed to research in topics: Receptor & Adenosine. The author has an hindex of 85, co-authored 444 publications receiving 22298 citations. Previous affiliations of Rafael Franco include University of Navarra & ESPCI ParisTech.
Papers
More filters
Journal ArticleDOI
Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1–A2A Receptor Heteromers
Francisco Ciruela,Vicent Casadó,Ricardo Gouveia Rodrigues,Rafael Luján,Javier Burgueño,Meritxell Canals,Janusz Borycz,Nelson Rebola,Steven R. Goldberg,Josefa Mallol,Antonio Cortés,Enric I. Canela,Juan F. López-Giménez,Graeme Milligan,Carme Lluís,Rodrigo A. Cunha,Sergi Ferré,Rafael Franco +17 more
TL;DR: It is demonstrated that heteromerization of adenosine A1 receptors and A2A receptors allowsAdenosine to exert a fine-tuning modulation of glutamatergic neurotransmission and that chronic caffeine treatment leads to modifications in the function of the A1R–A2AR heteromer that could underlie the strong tolerance to the psychomotor effects of caffeine.
Journal ArticleDOI
Alternatively activated microglia and macrophages in the central nervous system.
TL;DR: Cumulative evidence shows that microglia may undergo the alternative activation pathway, express M2-type markers and contribute to neuroprotection, and in the approaches available for its identification.
Journal ArticleDOI
Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors
Joëlle Hillion,Meritxell Canals,Maria Torvinen,Vicent Casadó,Rizaldy P. Scott,Anton Terasmaa,Anita C. Hansson,Stanley Watson,Mark E. Olah,Josefa Mallol,Enric I. Canela,Michele Zoli,Luigi F. Agnati,Carlos F. Ibáñez,Carme Lluís,Rafael Franco,Sergi Ferré,Sergi Ferré,Kjell Fuxe +18 more
TL;DR: The results give a molecular basis for adenosine-dopamine antagonism at the membrane level and have implications for treatment of Parkinson's disease and schizophrenia, in which D2R are involved.
Journal ArticleDOI
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes
Silvia Ginés,Joëlle Hillion,Maria Torvinen,Stéphane Le Crom,Vicent Casadó,Enric I. Canela,Sofia Rondin,J.Y. Lew,Stanley J. Watson,Michele Zoli,Luigi F. Agnati,Philippe Vernier,Carmen Lluis,Sergi Ferré,Kjell Fuxe,Rafael Franco +15 more
TL;DR: The A(1)R/D( 1)R heteromerization may be one molecular basis for the demonstrated antagonistic modulation of A(2)R of D(1]R receptor signaling in the brain and seems to be essential for the blockade of A-1-R agonist-induced A(3)R-induced coclustering and for the desensitization of the D(0)R agonists cAMP accumulation.
Journal ArticleDOI
Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization QUALITATIVE AND QUANTITATIVE ASSESSMENT BY FLUORESCENCE AND BIOLUMINESCENCE ENERGY TRANSFER
Meritxell Canals,Daniel Marcellino,Francesca Fanelli,Francisco Ciruela,Piero Benedetti,Steven R. Goldberg,Kim A. Neve,Kjell Fuxe,Luigi F. Agnati,Amina S. Woods,Sergi Ferré,Carme Lluís,Michel Bouvier,Rafael Franco +13 more
TL;DR: In this article, BRET and bioluminescence resonance energy transfer (BRET) techniques were used to confirm the occurrence of A2AR-D2R interactions in co-transfected cells.